Researchers have discovered a clever survival trick used by melanoma cells that helps them resist treatment. This new insight could lead to better...
Vous n'êtes pas connecté
Researchers have discovered a clever survival trick used by melanoma cells that helps them resist treatment. This new insight could lead to better ways to treat this deadly skin cancer and improve patient survival. Melanoma is the most dangerous type of skin cancer and is often caused by changes (mutations) in a gene called BRAF. […] The post How skin cancer outsmarts treatment and how to stop it appeared first on Knowridge Science Report.
Researchers have discovered a clever survival trick used by melanoma cells that helps them resist treatment. This new insight could lead to better...
A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one of the deadliest cancers...
Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems from both late detection...
Antibody treatment which activates the patient’s immune system against cancer, known as immunotherapy, is increasingly being investigated as an...
Antibody treatment which activates the patient’s immune system against cancer, known as immunotherapy, is increasingly being investigated as an...
A new study has found that firefighters may be more likely to develop specific gene mutations linked to gliomas, the most common type of malignant...
University of Queensland researchers are designing nanotechnology they believe could improve how we treat the most aggressive form of breast cancer.
University of Queensland researchers are designing nanotechnology they believe could improve how we treat the most aggressive form of breast cancer.
A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the Department of Surgery at the...
Researchers at the University of Colorado Anschutz Medical Campus, USA, have successfully developed a supercharged iteration of CAR-T cell therapy...